Back to Gene
XPA gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

XPA gene

The XPA gene plays a critical role in repairing damaged DNA, and mutations in this gene are associated with the severe condition xeroderma pigmentosum.

Normal Function

The XPA gene provides instructions for making a protein that is involved in repairing damaged DNA. DNA can be damaged by ultraviolet (UV) rays from sunlight and by toxic chemicals, radiation, and unstable molecules called free radicals.

DNA damage occurs frequently, but normal cells are usually able to fix it before it can cause problems. One of the major mechanisms that cells use to fix DNA is known as nucleotide excision repair (NER). As part of this repair mechanism, the XPA protein helps verify DNA damage and stabilize the DNA as it is repaired. The XPA protein attaches (binds) to areas of damaged DNA, where it interacts with many other proteins as part of a large complex. Proteins in this complex unwind the section of DNA where the damage has occurred, snip out (excise) the abnormal section, and replace the damaged area with the correct DNA.

Health Conditions Related to Genetic Changes

Xeroderma pigmentosum

Many variants (also called mutations) in the XPA gene have been found to cause xeroderma pigmentosum. People with this condition have an extreme sensitivity to UV rays from sunlight. As a result, affected individuals have a high risk of sunlight-induced cancer and premature aging.

XPA gene variants are responsible for a very severe form of xeroderma pigmentosum that is more common in the Japanese population than in other populations. Most Japanese people with xeroderma pigmentosum have the same XPA gene variant, which is written as IVS3AS, G>C. This variant prevents cells from producing any functional XPA protein. Other XPA gene variants, which have been reported in Japan and elsewhere, result in the production of a nonfunctional version of the XPA protein or greatly reduce the amount of this protein that is made in cells.

A partial or total loss of the XPA protein prevents cells from repairing DNA damage normally. As damage builds up in DNA, cells malfunction and eventually become cancerous or die. These problems with DNA repair cause people with xeroderma pigmentosum to be extremely sensitive to UV rays. When UV rays damage genes that control cell growth and division, cells can grow too fast and in an uncontrolled way. This uncontrolled cell growth can lead to cancer. In people with xeroderma pigmentosum, these cancers occur most frequently in areas of the body that are exposed to the sun, such as the skin and eyes.

When xeroderma pigmentosum is caused by XPA gene variants, it is often associated with progressive neurological abnormalities. These nervous system problems include hearing loss, poor coordination, difficulty walking, movement problems, loss of intellectual function, difficulty swallowing and talking, and seizures. The neurological abnormalities are thought to result from a buildup of DNA damage, although the brain is not exposed to UV rays. Researchers suspect that other factors damage DNA in nerve cells. It is unclear why some people with xeroderma pigmentosum develop neurological abnormalities and others do not.

Other Names for This Gene

  • xeroderma pigmentosum, complementation group A
  • XP1
  • XPA_HUMAN
  • XPAC

Frequently Asked Questions

Strict lifelong protection from all sources of ultraviolet (UV) light is crucial. This includes wearing UV-protective clothing, wide-brimmed hats, sunglasses, and broad-spectrum sunscreen with high SPF daily, even indoors near windows. Avoid direct sun exposure, especially during peak hours, and use UV-blocking films on windows at home and in cars. Regular skin checks by a dermatologist are also essential for early detection of any skin cancers.
Yes, xeroderma pigmentosum caused by XPA gene mutations is an inherited condition, typically following an autosomal recessive pattern. This means a child must inherit two copies of the mutated XPA gene (one from each parent) to develop the condition. Parents who each carry one copy of the mutated gene are usually unaffected but have a 25% chance with each pregnancy of having a child with XP. Genetic counseling can help families understand inheritance patterns and reproductive options.
Individuals with an XPA gene mutation require comprehensive, lifelong medical management. This typically involves frequent full-body skin examinations by a dermatologist (every 3-6 months) to screen for skin cancers, regular eye exams by an ophthalmologist due to ocular sensitivity, and neurological evaluations as some forms of XP can have neurological involvement. Regular dental check-ups are also important.
The earliest signs of XPA-related xeroderma pigmentosum often include severe sunburn after minimal sun exposure, freckling at a young age, and dry skin. Over time, affected individuals may develop numerous dark spots, thin skin, and growths on sun-exposed areas. Any unusual skin changes, especially in childhood, warrant immediate consultation with a dermatologist or geneticist.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA